Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
PEPE price reached $0.00002158 per piece, down -3.05% during the day

PEPE price reached $0.00002158 per piece, down -3.05% during the day

Bitget2024/12/05 19:06

Pepe real time price quote, PEPE latest price today reached $0.00002158, down as much as -3.05%, with a trading volume of $5.096 billion Analysed by the k-chart, it is currently in an oscillating trend. It is down sharply from 14:00, up from 07:00 and down from 12:00. Trading volume is down and price is up. The Williams indicator suggests that this is a period of no overbought and oversold. Trading volume has decreased recently, trading volume is lower than in the previous hours, price is rising, trading volume is falling: upward momentum is weakening. The market direction is unclear and the upward momentum is weakening, so it is recommended to remain on the sidelines and wait for a clear signal. The above is for reference only and does not constitute investment advice.

2
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.

Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.

智通财经•2026/09/29 03:11

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46